Premium
Effects of supplemental calcium and vitamin D on tight‐junction proteins and mucin‐12 expression in the normal rectal mucosa of colorectal adenoma patients
Author(s) -
Mandle Hannah B.,
Jahan Ferdous A.,
Bostick Roberd M.,
Baron John A.,
Barry Elizabeth L.,
Yacoub Rami,
Merrill Julia,
Rutherford Robin E.,
Seabrook March E.,
Fedirko Veronika
Publication year - 2019
Publication title -
molecular carcinogenesis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.254
H-Index - 97
eISSN - 1098-2744
pISSN - 0899-1987
DOI - 10.1002/mc.23010
Subject(s) - vitamin d and neurology , colorectal adenoma , mucin 2 , colorectal cancer , mucin , medicine , biology , calcium , gastroenterology , endocrinology , adenoma , vitamin , immunohistochemistry , occludin , intestinal mucosa , tight junction , cancer , gene expression , biochemistry , gene
The physical gut barrier, comprised of a thick mucus layer and the epithelium, plays an important role in defense against microbes and foreign antigens. Calcium and vitamin D may be involved in maintaining the integrity of the intestinal mucosal barrier, the dysfunction of which may lead to endotoxemia and inflammation, and contribute to colorectal carcinogenesis. We investigated supplemental calcium (1200 mg, daily) and/or vitamin D 3 (1000 IU daily) effects on intestinal barrier function‐related biomarkers in a subset of 105 participants from a large colorectal adenoma recurrence chemoprevention clinical trial. We assessed expression of the tight junction proteins claudin‐1 (CLDN1), occludin (OCLD), and mucin‐12 (MUC12) in the normal‐appearing colorectal mucosa using standardized, automated immunohistochemistry and quantitative image analysis. Following 1 year of treatment, in the calcium relative to the no calcium group, the CLDN1, OCLD, and MUC12 expression increased by 14% ( P = 0.17), 23% ( P = 0.11), and 22% ( P = 0.07), respectively. In secondary analyses, the estimated calcium treatment effects were greater among participants with baseline serum 25‐OH‐vitamin D concentrations below the median value of 22.69 ng/mL (CLDN1: 29%, P = 0.04; OCLD: 36%, P = 0.06; MUC12: 35%, P = 0.05). There were no biomarker expression changes in the vitamin D 3 alone group; however, modest increases were found in the combined calcium/vitamin D 3 group. At baseline, obesity, history of a sessile‐serrated adenoma, colorectal MIB‐1/Ki‐67 expression, and a family history of colorectal cancer were associated with CLDN1, OCLD, and MUC12 expression. Our study supports continued investigation of factors that could affect intestinal mucosal barrier integrity relevant to colorectal carcinogenesis.